Disease × agent pairs

Benign Prostatic Hyperplasia (BPH): candidate agents with evidence

1 agents linked to Benign Prostatic Hyperplasia by at least one registered trial or two publications, ranked by the OSMF evidence score. Not treatment advice.

Prazosin

Drug · tier A · 8 trials (0 recruiting) · 8 publications · score 63.5

Research map, not treatment advice. Built 2026-11-22.